Project Details
Description
PRESTO; Characterization and clinical outcomes of Alopecia Areata (AA) patients treated with ritlecitinib in a real-world (RW) cohort: A multinational, prospective observational study
| Status | Active |
|---|---|
| Effective start/end date | 6/10/24 → 6/9/35 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.